Completed OBSERVATIONAL NCT05793515

Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models

Understanding Genetic Missing Variability and Pathogenetic Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models

Sponsor: Fondazione G.B. Bietti, IRCCS

Conditions Inherited Retinal Dystrophy Macular Dystrophy Retinitis Pigmentosa

Interventions whole genome sequencing

Updated 4 times since 2023 Last updated: Apr 15, 2025 Started: Nov 15, 2022 Primary completion: Nov 2, 2024 Completion: Nov 2, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05793515, this observational or N/A phase trial focuses on Inherited Retinal Dystrophy and Macular Dystrophy and remains completed. Sponsored by Fondazione G.B. Bietti, IRCCS, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

May 2025 — Present [monthly]

Completed

Status: Recruiting → Completed
Sep 2024 — May 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Nov 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione G.B. Bietti, IRCCS
Istituto Superiore di Sanità
Ospedale Pediatrico Bambin Gesù

Data source: Istituto Superiore di Sanità

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy